Working to recover from a damaging cyberattack, Merck reported that its star HPV vaccine missed sales expectations in the third quarter as it had to borrow from the CDC’s stockpile to fulfill orders. More: Merck hack causes Gardasil sales miss
read moreSwiss drugmaker Roche has pulled a cancer drug from the Greek market as it does battle again with authorities in the financially exhausted country over steps they have taken against drug prices in an effort to appease lenders. More: Roche
read morePersonalized vaccines are mostly used in cancer, but what about prophylactic vaccines against infectious diseases? Sanofi Pasteur has tapped Berg’s artificial intelligence capabilities to discover biomarkers that could help scientists learn more about individual flu vaccine responses. More: Sanofi inks
read moreAbbVie and Johnson & Johnson got a scare this Halloween, and it came in the form of an FDA approval for AstraZeneca’s Imbruvica rival. AZ certainly hopes the medication pays off: It was the centerpiece of a $4 billion-plus deal
read morePfizer CEO Ian Read on Tuesday offered up prescription trends and launch details on the company’s key products, including the cancer therapies Ibrance and Xtandi. But it didn’t take long for analysts to turn the conversation back to their favorite
read moreGW Pharmaceuticals and its US subsidiary Greenwich Biosciences have completed the rolling submission of Epidiolex as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome, two difficult-to-treat forms of childhood-onset epilepsy. More: GW completes Epidiolex submission Source: News
read more© 1994 - 2024 B.M. Pharmaceuticals